Los Angeles Capital Management LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$17.63 - $21.74 $129,263 - $159,397	-7,332 Reduced 4.98%	139,850 $2.76 Million
Q4 2023 Feb 06, 2024	BUY	$14.37 - $19.07 $22,129 - $29,367	1,540 Added 1.06%	147,182 $2.58 Million
Q3 2023 Nov 06, 2023	SELL	$13.62 - $20.2 $200,922 - $297,990	-14,752 Reduced 9.2%	145,642 $2.53 Million
Q2 2023 Aug 03, 2023	BUY	$10.44 - $16.48 $488,038 - $770,390	46,747 Added 41.13%	160,394 $2.26 Million
Q1 2023 May 04, 2023	SELL	$10.7 - $15.79 $43,431 - $64,091	-4,059 Reduced 3.45%	113,647 $1.22 Million
Q4 2022 Feb 06, 2023	SELL	$11.42 - $17.05 $60,343 - $90,092	-5,284 Reduced 4.3%	117,706 $1.76 Million
Q3 2022 Nov 02, 2022	BUY	$9.76 - $13.41 $560,302 - $769,841	57,408 Added 87.54%	122,990 $1.58 Million
Q2 2022 Aug 05, 2022	BUY	$7.6 - $11.41 $1,976 - $2,966	260 Added 0.4%	65,582 $635,000
Q1 2022 May 06, 2022	BUY	$9.3 - $12.37 $49,773 - $66,204	5,352 Added 8.92%	65,322 $649,000
Q4 2021 Feb 03, 2022	BUY	$10.39 - $15.15 $289,735 - $422,472	27,886 Added 86.92%	59,970 $706,000
Q3 2021 Nov 08, 2021	SELL	$11.39 - $16.23 $155,951 - $222,221	-13,692 Reduced 29.91%	32,084 $365,000
Q2 2021 Aug 05, 2021	BUY	$13.22 - $19.09 $310,180 - $447,908	23,463 Added 105.15%	45,776 $638,000
Q1 2021 May 05, 2021	SELL	$16.68 - $23.97 $96,910 - $139,265	-5,810 Reduced 20.66%	22,313 $413,000
Q4 2020 Feb 04, 2021	BUY	$14.8 - $21.15 $23,546 - $33,649	1,591 Added 6.0%	28,123 $497,000
Q3 2020 Nov 02, 2020	BUY	$15.21 - $25.53 $63,562 - $106,689	4,179 Added 18.7%	26,532 $406,000
Q2 2020 Aug 05, 2020	BUY	$15.08 - $26.0 $66,548 - $114,738	4,413 Added 24.6%	22,353 $569,000
Q1 2020 May 04, 2020	BUY	$11.0 - $19.76 $53,900 - $96,824	4,900 Added 37.58%	17,940 $278,000
Q4 2019 Feb 07, 2020	BUY	$5.24 - $12.96 $68,329 - $168,998	13,040 New	13,040 $144,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.4 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.06 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.96 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$790,904
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$600,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account